Papers - YONEYAMA Tohru
-
Humoral response after SARS-CoV-2 mRNA vaccination in patients with prostate cancer using steroids.
Noritaka Ishii, Shingo Hatakeyama, Tohru Yoneyama, Ryuma Tanaka, Takuma Narita, Naoki Fujita, Teppei Okamoto, Hayato Yamamoto, Takahiro Yoneyama, Yasuhiro Hashimoto, Chikara Ohyama
Urologic oncology 40 ( 10 ) 451.e1 - 451.e8 2022.10
-
Proportion of patients eligible for adjuvant immunotherapy in nonmetastatic clear-cell renal cell carcinoma treated with radical or partial nephrectomy.
Tanaka R, Hatakeyama S, Miura H, Hamaya T, Yoneyama T, Ohyama C
International journal of urology : official journal of the Japanese Urological Association 29 ( 10 ) 1235 - 1237 2022.10
-
Risk score-based substratification improves surveillance costs after transurethral resection of bladder tumor in patients with primary high-risk non-muscle-invasive bladder cancer.
Naoki Fujita, Shingo Hatakeyama, Masaki Momota, Yuki Tobisawa, Tohru Yoneyama, Hayato Yamamoto, Hiroyuki Ito, Takahiro Yoneyama, Yasuhiro Hashimoto, Kazuaki Yoshikawa, Chikara Ohyama
Scientific reports 12 ( 1 ) 13786 - 13786 2022.8
-
Selective reaction monitoring approach using structure-defined synthetic glycopeptides for validating glycopeptide biomarkers pre-determined by bottom-up glycoproteomics.
Kouta Shiratori, Yasuhiro Yokoi, Hajime Wakui, Nozomi Hirane, Michiru Otaki, Hiroshi Hinou, Tohru Yoneyama, Shingo Hatakeyama, Satoshi Kimura, Chikara Ohyama, Shin-Ichiro Nishimura
RSC advances 12 ( 33 ) 21385 - 21393 2022.7
-
Impact of body size on skin-related adverse events in advanced prostate cancer treated with apalutamide: A multicenter retrospective study.
Sasaki D, Hatakeyama S, Tanaka T, Okamoto T, Yoneyama T, Ohyama C
International journal of urology : official journal of the Japanese Urological Association 29 ( 7 ) 772 - 773 2022.7
-
Kidney Transplantation in a Patient With Noonan Syndrome: A Case Report.
Kodama H, Hatakeyama S, Hamaya T, Murakami R, Murasawa H, Yamamoto H, Yoneyama T, Ohyama C
Transplantation proceedings 54 ( 6 ) 1601 - 1603 2022.7
-
Significance of pelvic lymph node dissection during radical prostatectomy in high-risk prostate cancer patients receiving neoadjuvant chemohormonal therapy.
Hiromichi Iwamura, Shingo Hatakeyama, Takuma Narita, Yusuke Ozaki, Sakae Konishi, Hirotaka Horiguchi, Hirotake Kodama, Yuta Kojima, Naoki Fujita, Teppei Okamoto, Yuki Tobisawa, Tohru Yoneyama, Hayato Yamamoto, Takahiro Yoneyama, Yasuhiro Hashimoto, Chikara Ohyama
Scientific reports 12 ( 1 ) 9675 - 9675 2022.6
-
Association between Aortic Calcification Burden and the Severity of Erectile Dysfunction in Men Undergoing Dialysis: A Cross-Sectional Study.
Naoki Fujita, Shingo Hatakeyama, Masaki Momota, Yuki Tobisawa, Tohru Yoneyama, Teppei Okamoto, Hayato Yamamoto, Takahiro Yoneyama, Yasuhiro Hashimoto, Kazuaki Yoshikawa, Chikara Ohyama
The world journal of men's health 41 ( 2 ) 373 - 381 2022.5
-
Single immediate instillation of chemotherapy is associated with decreased recurrence and progression in patients with high-risk non-muscle-invasive bladder cancer who receive adjuvant induction bacillus Calmette-Guérin therapy.
Naoki Fujita, Shingo Hatakeyama, Masaki Momota, Takuma Narita, Yuki Tobisawa, Tohru Yoneyama, Hayato Yamamoto, Hiroyuki Ito, Takahiro Yoneyama, Yasuhiro Hashimoto, Kazuaki Yoshikawa, Chikara Ohyama
International journal of urology : official journal of the Japanese Urological Association 29 ( 8 ) 867 - 875 2022.5
-
Machine learning diagnosis by immunoglobulin N-glycan signature for precision diagnosis of urological diseases.
Hiromichi Iwamura, Kei Mizuno, Shusuke Akamatsu, Shingo Hatakeyama, Yuki Tobisawa, Shintaro Narita, Takuma Narita, Shinichi Yamashita, Sadafumi Kawamura, Toshihiko Sakurai, Naoki Fujita, Hirotake Kodama, Daisuke Noro, Ikuko Kakizaki, Shigeyuki Nakaji, Ken Itoh, Norihiko Tsuchiya, Akihiro Ito, Tomonori Habuchi, Chikara Ohyama, Tohru Yoneyama
Cancer science 113 ( 7 ) 2434 - 2445 2022.5
-
Renal metastasis of ovarian granulosa cell tumor.
Kyo Togashi, Tohru Yoneyama, Mihoko Sutoh Yoneyama, Hayato Yamamoto, Shingo Hatakeyama, Takahiro Yoneyama, Yasuhiro Hashimoto, Masayuki Futagami, Chikara Ohyama
IJU case reports 5 ( 3 ) 186 - 190 2022.5
-
Effect of upfront combination therapy on the overall survival of patients with metastatic castration-sensitive prostate cancer: A multicenter retrospective study.
Tanaka T, Hatakeyama S, Noro D, Togashi K, Yoneyama T, Ohyama C
International journal of urology : official journal of the Japanese Urological Association 29 ( 5 ) 476 - 478 2022.5
-
TMEM2 expression is downregulated as bladder cancer invades the muscle layer.
Mihoko Sutoh Yoneyama, Tohru Yoneyama, Yuki Tobisawa, Hayato Yamamoto, Shingo Hatakeyama, Takahiro Yoneyama, Yasuhiro Hashimoto, Tadashi Suzuki, Chikara Ohyama
Biochemical and biophysical research communications 613 1 - 6 2022.4
-
Seroprevalence of SARS-CoV-2 spike IgG antibodies after the second BNT162b2 mRNA vaccine in Japanese kidney transplant recipients.
Tomoko Hamaya, Shingo Hatakeyama, Tohru Yoneyama, Yuki Tobisawa, Hirotake Kodama, Takeshi Fujita, Reiichi Murakami, Naoki Fujita, Teppei Okamoto, Hayato Yamamoto, Takahiro Yoneyama, Yasuhiro Hashimoto, Hisao Saitoh, Shunji Narumi, Hirofumi Tomita, Chikara Ohyama
Scientific reports 12 ( 1 ) 5876 - 5876 2022.4
-
Effect of active anticancer therapy on serologic response to SARS-CoV-2 BNT162b2 vaccine in patients with urothelial and renal cell carcinoma.
Kyo Togashi, Shingo Hatakeyama, Tohru Yoneyama, Tomoko Hamaya, Takuma Narita, Naoki Fujita, Hiromichi Iwamura, Teppei Okamoto, Hayato Yamamoto, Takahiro Yoneyama, Yasuhiro Hashimoto, Chikara Ohyama
International journal of urology : official journal of the Japanese Urological Association 29 ( 7 ) 733 - 739 2022.3
-
Effect of advanced glycation end products on nocturia or sleep disorders: A longitudinal study.
Konishi S, Hatakeyama S, Imai A, Okita K, Kido K, Ozaki Y, Uemura N, Iwane T, Okamoto T, Yamamoto H, Yoneyama T, Hashimoto Y, Ohyama C
BJUI compass 3 ( 2 ) 162 - 168 2022.3
-
The impact of eligibility for maintenance immunotherapy on prognosis in patients with unresectable or metastatic urothelial carcinoma.
Ozaki K, Hatakeyama S, Tanaka T, Noro D, Tokui N, Horiguchi H, Okuyama Y, Fujita N, Okamoto T, Okamoto A, Suzuki Y, Yamamoto H, Yoneyama T, Hashimoto Y, Ohyama C
BJUI compass 3 ( 2 ) 139 - 145 2022.3
-
Prognostication in Japanese patients with bacillus Calmette-Guérin-unresponsive non-muscle-invasive bladder cancer undergoing early radical cystectomy.
Nishimura N, Miyake M, Iida K, Miyamoto T, Tomida R, Numakura K, Inokuchi J, Yoneyama T, Matsumura Y, Yajima S, Masuda H, Terada N, Taoka R, Kobayashi T, Kojima T, Matsui Y, Nishiyama N, Kitamura H, Nishiyama H, Fujimoto K
International journal of urology : official journal of the Japanese Urological Association 29 ( 3 ) 242 - 249 2022.3
-
Prognostic impact of proton pump inhibitors for immunotherapy in advanced urothelial carcinoma.
Okuyama Y, Hatakeyama S, Numakura K, Narita T, Tanaka T, Miura Y, Sasaki D, Noro D, Tokui N, Okamoto T, Yamamoto H, Narita S, Yoneyama T, Hashimoto Y, Habuchi T, Ohyama C
BJUI compass 3 ( 2 ) 154 - 161 2022.3
-
Prognostic impact of eligibility for adjuvant immunotherapy in locally advanced urothelial cancer.
Miura Y, Hatakeyama S, Tanaka T, Fujita N, Horiguchi H, Okuyama Y, Kojima Y, Noro D, Tokui N, Okamoto T, Yamamoto H, Ito H, Yoneyama T, Hashimoto Y, Ohyama C
BJUI compass 3 ( 2 ) 146 - 153 2022.3